BTIG analyst Thomas Shrader maintained a Buy rating on Alector (ALEC – Research Report) yesterday and set a price target of $5.00. The ...

In a report released yesterday, Thomas Shrader from BTIG maintained a Buy rating on Denali Therapeutics (DNLI – Research Report), with a price ...

Analysts at BTIG moved to the sidelines on online dating apps company Match Group (NASDAQ:MTCH) and lowered its investment ...

The economic fundamentals of Wednesday's inflation report will doubtless impact stocks. But before that let's have a chartist view from BTIG's technical guru Jonathan Krinsky. He notes that the S&P 50 ...

Strong order growth also contributed to BTIG’s upgrade to Buy from Neutral, with grocery delivery remaining one of the few ...

In recent trading, P3 Health Partners Inc (PIII) stock price has shown some volatility, fluctuating -13.35% over the last five trades a ...

Genius Sports Limited (NYSE: GENI) (“Genius Sports,” the “Company,” “we” or “our”) announced today the pricing of an underwritten public offering of 1 ...

Match's valuation is also a concern. At 10x EBITDA with declining revenue, the multiple is seen as "full," limiting upside ...

Get the latest updates from the ICR Conference, including holiday sales reports, earnings outlooks, and top picks in retail ...

Palo Alto Networks Inc (PANW) stock saw a modest uptick, ending the day at $170.58 which represents a slight increase of $2.76 or 1.64% from the prior close of $167.82. The stock opened at $168.3 and ...

BTIG Research began coverage on shares of ImmunityBio (NASDAQ:IBRX – Free Report) in a report released on Friday morning, Marketbeat reports. The firm issued a buy rating and a $6.00 price target on ...

BTIG analyst Thomas Shrader lowered the firm’s price target on Denali Therapeutics (DNLI) to $32 from $35 and keeps a Buy rating on the shares after the company announced topline data from the Phase 2 ...